Atai Beckley N.V. 4 SEC Filings

Filed On	Filing
26 Nov 2025	Form 4: Feilding-Mellen Cosmo, Director Disposed of 40,400 Stock Option (Disposition to Issuer) · Granted 10,000 Stock Option
06 Nov 2025	Form 4: Hershberg Robert, Director Granted 719,121 Stock Option
06 Nov 2025	Form 4: Feilding-Mellen Cosmo, Director Received 7,702,990 shares as a grant or award · Granted 143,400 Stock Option
06 Nov 2025	Form 4: Braunstein Scott, Director Granted 56,818 Stock Option
03 Oct 2025	Form 4: Barrett Christopher Ryan Cave, See Remarks Granted 175,000 Stock Option
02 Oct 2025	Form 4: Apeiron Investment Group Ltd., 10% owner and 1 other Received 2,367,200 shares by conversion
18 Aug 2025	Form 4: Apeiron Investment Group Ltd., 10% owner and 1 other Bought 8,675,799 shares ($19M)
15 Aug 2025	Form 4: Rao Srinivas, See Remarks Granted 868,571 Stock Option
27 Jun 2025	Form 4: Smiley Andrea Heslin, Director Granted 103,000 Stock Option
27 Jun 2025	Form 4: Kalali Amir H, Director Granted 103,000 Stock Option
27 Jun 2025	Form 4: Johnson Sabrina Martucci, Director Granted 103,000 Stock Option
27 Jun 2025	Form 4: Hoffman John Francis, Director Granted 206,000 Stock Option
27 Jun 2025	Form 4: Fischer Laurent, Director Granted 103,000 Stock Option
27 Jun 2025	Form 4: Braunstein Scott, Director Granted 103,000 Stock Option
27 Jun 2025	Form 4: Angermayer Christian, Director Granted 103,000 Stock Option
04 Jun 2025	Form 4: Angermayer Christian, Director Granted 131,698 Stock Option
24 Mar 2025	Form 4: Rao Srinivas, See Remarks Sold 75,418 shares ($102K)
24 Mar 2025	Form 4: Kirpekar Sahil, Chief Business Officer Sold 48,563 shares ($65.6K)
24 Mar 2025	Form 4: Craig Kevin James, Chief Medical Officer Sold 11,563 shares ($15.6K)
24 Mar 2025	Form 4: Johnson Anne Nagengast, Chief Financial Officer Sold 33,545 shares ($45.3K)

Comments